Search Results - "Yowell, Robert L"

Refine Results
  1. 1

    Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients by Shaddy, Robert E., Hammond, Elizabeth H., Yowell, Robert L.

    Published in The American journal of cardiology (01-06-1996)
    “…The purposes of this study were to examine 250 heart biopsy specimens and 20 autopsy specimens from heart transplant patients for the presence and localization…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Neuroendocrine carcinomas: Role of immunocytochemistry and electron microscopy by Hammond, Elizabeth H, Yowell, Robert L, Flinner, Robert L

    Published in Human pathology (01-12-1998)
    “…Neuroendocrine tumors occur in many sites of the body and can present significant diagnostic problems when poorly differentiated. To identify a tumor as…”
    Get full text
    Journal Article
  4. 4

    Endocardial Fibrosis Associated with Fenfluramine–Phentermine by Fowles, Robert E, Cloward, Tom V, Yowell, Robert L

    Published in The New England journal of medicine (30-04-1998)
    “…To the Editor: It has been previously reported that valvular heart disease may be associated with the use of anorectic drugs. 1 We report a case of restrictive…”
    Get full text
    Journal Article
  5. 5

    THE FIRST PEDIATRIC JAPANESE CASE TO UNDERGO HEART TRANSPLANTATION IN THE UTAH CARDIAC TRANSPLANT PROGRAM IN THE UNITED STATES by NUNODA, SHINICHI, E., SHADDY ROBERT, A., BULLOCK EMILY, G., RENLUND DALE, H., HAMMOND ELIZABETH, L., YOWELL ROBERT, MISAWA, TAKUO, UMETANI, KEN, SATOH, HITOMI

    Published in JAPANESE CIRCULATION JOURNAL (1993)
    “…A seven-year-old girl underwent heart transplantation because of progressive congestive heart failure resulting from familial dilated cardiomyopathy. Her…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    The repetitive histologic pattern of vascular cardiac allograft rejection : Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3) by MA, H, HAMMOND, E. H, TAYLOR, D. O, YOWELL, R. L, BRISTOW, M. R, O'CONNELL, J. B, RENLUND, D. G

    Published in Transplantation (27-07-1996)
    “…While vascular cardiac allograft rejection increases morbidity and mortality following transplantation, factors predisposing to its development have not been…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis by Hammond, E H, Wittwer, C T, Greenwood, J, Knape, W A, Yowell, R L, Menlove, R L, Craven, C, Renlund, D G, Bristow, M R, DeWitt, C W

    Published in Transplantation (01-11-1990)
    “…We prospectively and serially monitored plasma levels of OKT3 in 20 patients who were receiving 14- or 21-day rejection prophylaxis with OKT3. We…”
    Get more information
    Journal Article
  11. 11

    Prevention of adverse clinical outcome by monitoring of cardiac transplant patients for murine monoclonal CD3 antibody (OKT3) sensitization by Hammond, E A, Yowell, R L, Greenwood, J, Hartung, L, Renlund, D, Wittwer, C

    Published in Transplantation (01-05-1993)
    “…We have previously reported that patients sensitized to murine monoclonal CD3 antibody (OKT3) and maintained on such therapy for induction of immunosuppression…”
    Get more information
    Journal Article
  12. 12

    Ultrastructural findings in cardiac transplant recipients by Hammond, E H, Yowell, R L

    Published in Ultrastructural pathology (01-01-1994)
    “…Ultrastructural findings in 350 endomyocardial biopsy specimens and 59 autopsy or explanted hearts from cardiac transplant recipients are reviewed. Myocyte…”
    Get more information
    Journal Article
  13. 13

    Correlation between cellular rejection of cardiac allografts and quantitative changes among T-cell subsets identified by Vβ epitope expression by CARLQUIST, J. F, HAMMOND, M. E, YOWELL, R. L, HOLLAND, C, SWANSON, S, ANDERSON, J. L

    Published in Circulation (New York, N.Y.) (01-08-1994)
    “…Cellular rejection of an allograft is mediated in part by peripheral blood T cells. We tested the hypothesis that quantitative changes in T-cell subsets can be…”
    Get full text
    Journal Article
  14. 14

    Cardiac paraprotein associated with Waldenstrom's macroglobulinemia: a case report by Yowell, R L, Hammond, E H

    Published in Ultrastructural pathology (01-01-1994)
    “…A case of myocardial paraprotein deposition in a patient with Waldenstrom's macroglobulinemia is presented. Routine light microscopy revealed diffuse widening…”
    Get more information
    Journal Article
  15. 15
  16. 16

    The role of electron microscopy in evaluating ciliary dysfunction: report of a workshop by Mierau, G W, Agostini, R, Beals, T F, Carlén, B, Dardick, I, Henderson, D W, Pysher, T J, Weeks, D A, Yowell, R L

    Published in Ultrastructural pathology (01-01-1992)
    “…This report summarizes the proceedings of a workshop organized with the purpose of bringing together many of those with substantial experience in this…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Correlation between class II antigen (DR) expression and interleukin-2-induced lymphocyte proliferation during acute cardiac allograft rejection by Carlquist, J F, Hammond, M E, Yowell, R L, O'Connell, J B, Anderson, J L

    Published in Transplantation (01-10-1990)
    “…We have previously reported a correlation between biopsy-proven rejection and the presence of IL-2-responsive lymphocytes for biopsy specimens from human…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Efficacy of OKT3 retreatment for refractory cardiac allograft rejection by O'Connell, J B, Renlund, D G, Gay, Jr, W A, DeWitt, C W, Hammond, E H, Yowell, R L, Jones, K W, Karwande, S V, Doty, D B, Bristow, M R

    Published in Transplantation (01-05-1989)
    “…Although OKT3 monoclonal antibody is a useful therapy for refractory cardiac allograft rejection, the use of OKT3 for prophylaxis may be limited by the…”
    Get more information
    Journal Article